{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:56:11Z","timestamp":1760424971673},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/fjc.0b013e3181de308b","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T09:42:01Z","timestamp":1269596521000},"page":"53-59","source":"Crossref","is-referenced-by-count":7,"title":["Ameliorative Role of Rosiglitazone in Hyperhomocysteinemia-Induced Experimental Cardiac Hypertrophy"],"prefix":"10.1097","volume":"56","author":[{"given":"Amrit Pal","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randhir Singh","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preet Mohinder","family":"Singh Bedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210208","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic implications of left ventricular hypertrophy.","volume":"141","author":"Vakili","year":"2001","journal-title":"Am Heart J"},{"key":"R2-8-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2007.01.003","article-title":"Rodent models of heart failure.","volume":"56","author":"Balakumar","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R3-8-20210208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3923\/tmr.2007.160.166","article-title":"Hyperhomocysteinemia and cardiovascular disorders: is there a correlation?","volume":"2","author":"Balakumar","year":"2007","journal-title":"Trends Med Res"},{"key":"R4-8-20210208","doi-asserted-by":"crossref","first-page":"H679","DOI":"10.1152\/ajpheart.00145.2003","article-title":"Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats.","volume":"285","author":"Joseph","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R5-8-20210208","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/FJC.0b013e31817ae60f","article-title":"Effect of mast cell stabilizers in hyperhomo-cysteinemia-induced cardiac hypertrophy in rats.","volume":"51","author":"Singh","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"R6-8-20210208","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejheart.2005.11.016","article-title":"A review of homocysteine and heart failure.","volume":"8","author":"Herrmann","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R7-8-20210208","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists.","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"R8-8-20210208","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","article-title":"Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.","volume":"108","author":"Tao","year":"2003","journal-title":"Circulation"},{"key":"R9-8-20210208","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/hc4601.099403","article-title":"In vivo myocardial protection from ischemia\/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.","volume":"104","author":"Yue Tl","year":"2001","journal-title":"Circulation"},{"key":"R10-8-20210208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3132\/dvdr.2007.029","article-title":"Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat.","volume":"4","author":"Bolten","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"R11-8-20210208","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"key":"R12-8-20210208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000103917","article-title":"Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.","volume":"80","author":"Rose","year":"2007","journal-title":"Pharmacology"},{"key":"R13-8-20210208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.metabol.2004.12.008","article-title":"Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.","volume":"54","author":"Murthy","year":"2005","journal-title":"Metabolism"},{"key":"R14-8-20210208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.33549\/physiolres.930150","article-title":"Captopril fails to reverse hypertrophy of the left ventricle induced by aortic insufficiency.","volume":"51","author":"Simko","year":"2002","journal-title":"Physiol Res"},{"key":"R15-8-20210208","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thio-barbituric acid reaction.","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"R16-8-20210208","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with folin-phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"R17-8-20210208","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.RES.82.7.810","article-title":"Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide.","volume":"82","author":"Wang","year":"1998","journal-title":"Circ Res"},{"key":"R18-8-20210208","first-page":"882","article-title":"Improved method for the determination of blood glutathione.","volume":"61","author":"Beutler","year":"1963","journal-title":"J Lab Clin Med"},{"key":"R19-8-20210208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardiores.2003.12.005","article-title":"Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse.","volume":"61","author":"Mori","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R20-8-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10520298709107961","article-title":"Picrosirius red staining of cardiac muscle following phosphomolybdic acid treatment.","volume":"62","author":"Dolber","year":"1987","journal-title":"Stain Technol"},{"key":"R21-8-20210208","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1291\/hypres.30.863","article-title":"Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.","volume":"30","author":"Shinzato","year":"2007","journal-title":"Hypertens Res"},{"key":"R22-8-20210208","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress.","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R23-8-20210208","doi-asserted-by":"crossref","first-page":"F671","DOI":"10.1152\/ajprenal.2000.279.4.F671","article-title":"Effects of homocysteine on endothelial nitric oxide production.","volume":"279","author":"Zhang","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"R24-8-20210208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(97)00090-7","article-title":"Stimulation of endothelial nitric oxide production by homocyst(e)ine.","volume":"132","author":"Upchurch","year":"1997","journal-title":"Atherosclerosis"},{"key":"R25-8-20210208","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0703149","article-title":"Peroxisome proliferator-activated receptors in the cardio-vascular system.","volume":"129","author":"Bishop-Bailey","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R26-8-20210208","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.RES.0000064382.46274.95","article-title":"PPARs of the heart: three is a crowd.","volume":"92","author":"Kelly","year":"2003","journal-title":"Circ Res"},{"key":"R27-8-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000074673","article-title":"Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II.","volume":"70","author":"Bonaventura","year":"2004","journal-title":"Pharmacology"},{"key":"R28-8-20210208","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0008-6363(99)00202-3","article-title":"Is there a local renin-angiotensin system in the heart?","volume":"44","author":"Danser","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R29-8-20210208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3317\/jraas.2006.039","article-title":"The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.","volume":"7","author":"Kassab","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R30-8-20210208","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cbf.1621","article-title":"The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.","volume":"28","author":"Ren","year":"2010","journal-title":"Cell Biochem Funct"},{"key":"R31-8-20210208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-008-9848-8","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin\/NFAT signaling pathway.","volume":"317","author":"Bao","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"R32-8-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2006.07.026","article-title":"Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats.","volume":"76","author":"Golbahar","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"R33-8-20210208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling.","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"R34-8-20210208","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.ATV.0000061735.85377.40","article-title":"Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase.","volume":"23","author":"Ungvari","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-8-20210208","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"R36-8-20210208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0065-2571(97)00010-1","article-title":"Regulation of mitogen-activated protein kinase cascades in the heart.","volume":"38","author":"Sugden","year":"1998","journal-title":"Adv Enzyme Regul"},{"key":"R37-8-20210208","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2007.05.222","article-title":"Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1\/2\/p38MAPK activation.","volume":"360","author":"Bai","year":"2007","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0b013e3181de308b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T10:05:37Z","timestamp":1711361137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-201007000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181de308b","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}